Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer

This study has been terminated.
(Follow up period after primary analysis was prematurely stopped because more mature data will not impact the study outcome)
Sponsor:
Information provided by (Responsible Party):
CureVac AG
ClinicalTrials.gov Identifier:
NCT01817738
First received: February 8, 2013
Last updated: February 15, 2017
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2017
  Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)